Polymorphisms of the cytomegalovirus (CMV)-encoded tumor necrosis factor-α and β-chemokine receptors in congenital CMV disease

Journal of Infectious Diseases

Volumn 186, Issue 8, 2002, Pages 1057-1064

  Arav Boger, Ravit ^a   Willoughby, Rodney E ^a   Pass, Robert F ^b   Zong, Jian Chao ^a   Jang, Won Jong ^a   Alcendor, Donald ^a   Hayward, Gary S ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b University of Alabama at Birmingham   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CHEMOKINE; CHEMOKINE RECEPTOR; DNA; TUMOR NECROSIS FACTOR ALPHA RECEPTOR; VIRUS GLYCOPROTEIN;

AMINO ACID SEQUENCE; ARTICLE; CLINICAL ARTICLE; CONGENITAL INFECTION; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; DNA SEQUENCE; GENOTYPE; HUMAN; NEWBORN; NONHUMAN; NUCLEOTIDE SEQUENCE; PHYLOGENY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RECEPTOR GENE; VIRUS CULTURE; VIRUS ENVELOPE; VIRUS GENOME; VIRUS INFECTION; VIRUS ISOLATION; VIRUS VIRULENCE;

AMINO ACID SEQUENCE; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; DISEASE TRANSMISSION, VERTICAL; FEMALE; GENES, VIRAL; GENOTYPE; HUMANS; INFANT, NEWBORN; INFANT, NEWBORN, DISEASES; MEMBRANE GLYCOPROTEINS; MOLECULAR SEQUENCE DATA; PHYLOGENY; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; PREGNANCY; RECEPTORS, CHEMOKINE; RECEPTORS, TUMOR NECROSIS FACTOR; VIRAL PROTEINS; VIRULENCE;

EID: 0037108926     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/344238     Document Type: Article

References (24)

1. Stagno S, Pass RF, Dworsky ME, et al. Congenital cytomegalovirus infection: the relative importance of primary and recurrent maternal infection. N Engl J Med 1982;306:945-9.
2. Preece PM, Tookey P, Ades A, Pechham CS. Congenital cytomegalovirus infection: predisposing maternal factors. J Epidemiol Community Health 1986;40:205-9.
3. Fowler KB. Stagno S. Pass RF. Maternal age and congenital cytomegalovirus infection: screening of two diverse newborn populations, 1980-1990. J Infect Dis 1993;168:552-6.
4. Cha TA, Tom E, Kemble GW. Duke GM, Mocarski ES, Spaete RR. Human cytomegalovirus clinical isolates carry at least 19 genes not found in laboratory strains. J Virol 1996;70:78-83.
5. Penfold ME, Dairaghi DJ, Duke GM, et al. Cytomegalovirus encodes a potent chemokine. Proc Natl Acad Sci USA 1999;96:9839-45.
6. Pleskoff O, Treboute C, Brelot A, Heveker N, Seman M, Alizon M. Identification of a chemokine receptor encoded by human cytomegalovirus as a cofactor for HIV-1 entry. Science 1997;276:1874-8.
7. Hengel H, Brune W. Koszinowski UH. Immune evasion by cytomegalovirus-survival strategies of a highly adapted opportunist. Trends Microbiol 1998;6:190-7.
8. Vieira J, Schall TJ, Corey L, Geballe AP. Functional analysis of the human cytomegalovirus US28 gene by insertion mutagenesis with the green fluorescent protein gene. J Virol 1998;72:8158-65.
9. Streblow DN, Soderberg-Naucler C, Vieira J, et al. The human cytomegalovirus chemokine receptor US28 mediates vascular smooth muscle cell migration. Cell 1999;99:511-20.
10. Shepp DH, Match ME, Ashraf AB, Lipson SM, Mitlan C, Pergolizzi R. Cytomegalovirus glycoprotein B groups associated with retinitis in AIDS. J Infect Dis 1996;174:184-7.
11. Torok-Storb B, Boeckh M, Hoy C, Leisenring W, Myerson D, Gooley T. Association of specific CMV genotypes with death from myelosuppression after marrow transplantation. Blood 1997;90:2097-102.
12. Fries BC, Chou S, Boeckh M, Torok-Storb B. Frequency distribution of cytomegalovirus envelope glycoprotein subtypes in bone marrow transplant recipients. J Infect Dis 1994;169:769-74.
13. Rasmussen L, Hong C, Zipeto D, et al. Cytomegalovirus gB genotype distribution differs in human immunodeficiency virus-infected patients and immunocompromised allograft recipients. J Infect Dis 1997;175:179-84.
14. Wada K, Mizuno S, Kato K, Kamiya T, Ozawa K. Cytomegalovirus glycoprotein B sequence variation among Japanese bone marrow transplant recipients. Intervirology 1997;40:215-9.
15. Meyer-König U, Vogelberg C, Bongarts A, et al. Glycoprotein B genotype correlates with cell tropism in vivo of human cytomegalovirus infection. J Med Virol 1998;55:75-81.
16. Lurain NS, Kapell KS, Huang DD, et al. Human cytomegalovirus ULI44 open reading frame sequence hypervariability in low-passage clinical isolates. J Virol 1999;73:10040-50.
17. Bale JF, Petheram SJ, Robertson M, Murph JR, Demmler G. Human cytomegalovirus a sequence and ULI44 variability in strains from infected children. J Med Virol 2001;65:90-6.
18. Benedict CA, Butrovich KD, Lurain NS, et al. Cutting edge: a novel viral TNF receptor superfamily member in virulent strains of human cytomegalovirus. J Immunol 1999;162:6967-70.
19. Staak K, Prösch S, Stein J, et al. Pentoxifylline promotes replication of human cytomegalovirus in vivo and in vitro. Blood 1997;89:3682-90.
20. Baldanti F, Sarasini A, Furione M, et al. Coinfection of the immunocompromised but not the immunocompetent host by multiple human cytomegalovirus strains. Arch Virol 1998;143:1701-9.
21. Bale JF, Petheram SJ, Souza IE, Murph JR. Cytomegalovirus reinfection in young children. J Pediatr 1996;128:347-52.
22. Boppana SB, Rivera LB, Fowler KB, Mach M, Britt WJ. Intrauterine transmission of cytomegalovirus to infants of women with preconceptional immunity. N Engl J Med 2001;344:1366-71.
23. Boppana SB, Fowler KB, Britt WJ, Stagno S, Pass RF. Symptomatic congenital cytomegalovirus infection in infants born to mothers with preexisting immunity to cytomegalovirus. Pediatrics 1999;104:55-60.
24. Geist LJ, Hinde SL. Susceptibility to cytomegalovirus infection may be dependent on the cytokine response to the virus. J Investig Med 2001;49:434-41.